Agrin-Lrp4 pathway in hippocampal astrocytes restrains development of temporal lobe epilepsy through adenosine signaling.

Autor: Liu ZY; School of Basic Medical Sciences, Key Laboratory of Neurogenetics and Channelopathies of Guangdong Province and the Ministry of Education of China, Institute of Neuroscience and Department of GFNeurology of the Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, China., Li YQ; School of Basic Medical Sciences, Key Laboratory of Neurogenetics and Channelopathies of Guangdong Province and the Ministry of Education of China, Institute of Neuroscience and Department of GFNeurology of the Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.; Department of Neurology of the Sixth Affiliated Hospital, Guangzhou Medical University, Guangzhou, China., Wang DL; Guangzhou Medical University-Guangzhou Institute of Biomedicine and Health (GMU-GIBH) Joint School of Life Sciences, Guangzhou Medical University, Guangzhou, China., Wang Y; School of Basic Medical Sciences, Key Laboratory of Neurogenetics and Channelopathies of Guangdong Province and the Ministry of Education of China, Institute of Neuroscience and Department of GFNeurology of the Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, China., Qiu WT; School of Basic Medical Sciences, Key Laboratory of Neurogenetics and Channelopathies of Guangdong Province and the Ministry of Education of China, Institute of Neuroscience and Department of GFNeurology of the Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.; Key Laboratory of Mental Health of the Ministry of Education, Guangdong-Hong Kong-Macao Greater Bay Area Center for Brain Science and Brain-Inspired Intelligence, Guangdong-Hong Kong Joint Laboratory for Psychiatric Disorders, Guangdong Province Key Laboratory of Psychiatric Disorders, Guangdong Basic Research Center of Excellence for Integrated Traditional and Western Medicine for Qingzhi Diseases, Department of Neurobiology, School of Basic Medical Sciences, Southern Medical University, Guangzhou, China., Qiu YY; School of Basic Medical Sciences, Key Laboratory of Neurogenetics and Channelopathies of Guangdong Province and the Ministry of Education of China, Institute of Neuroscience and Department of GFNeurology of the Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, China., Zhang HL; School of Basic Medical Sciences, Key Laboratory of Neurogenetics and Channelopathies of Guangdong Province and the Ministry of Education of China, Institute of Neuroscience and Department of GFNeurology of the Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, China., You QL; School of Basic Medical Sciences, Key Laboratory of Neurogenetics and Channelopathies of Guangdong Province and the Ministry of Education of China, Institute of Neuroscience and Department of GFNeurology of the Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, China., Liu SM; School of Basic Medical Sciences, Key Laboratory of Neurogenetics and Channelopathies of Guangdong Province and the Ministry of Education of China, Institute of Neuroscience and Department of GFNeurology of the Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, China., Liang QN; School of Basic Medical Sciences, Key Laboratory of Neurogenetics and Channelopathies of Guangdong Province and the Ministry of Education of China, Institute of Neuroscience and Department of GFNeurology of the Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, China., Wu EJ; School of Basic Medical Sciences, Key Laboratory of Neurogenetics and Channelopathies of Guangdong Province and the Ministry of Education of China, Institute of Neuroscience and Department of GFNeurology of the Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, China., Hu BJ; School of Basic Medical Sciences, Key Laboratory of Neurogenetics and Channelopathies of Guangdong Province and the Ministry of Education of China, Institute of Neuroscience and Department of GFNeurology of the Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, China. hubingjie@gzhmu.edu.cn., Sun XD; School of Basic Medical Sciences, Key Laboratory of Neurogenetics and Channelopathies of Guangdong Province and the Ministry of Education of China, Institute of Neuroscience and Department of GFNeurology of the Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, China. xisun@smu.edu.cn.; Key Laboratory of Mental Health of the Ministry of Education, Guangdong-Hong Kong-Macao Greater Bay Area Center for Brain Science and Brain-Inspired Intelligence, Guangdong-Hong Kong Joint Laboratory for Psychiatric Disorders, Guangdong Province Key Laboratory of Psychiatric Disorders, Guangdong Basic Research Center of Excellence for Integrated Traditional and Western Medicine for Qingzhi Diseases, Department of Neurobiology, School of Basic Medical Sciences, Southern Medical University, Guangzhou, China. xisun@smu.edu.cn.

Publikováno v: Cell & bioscience [Cell Biosci] 2024 May 23; Vol. 14 (1), pp. 66. Date of Electronic Publication: 2024 May 23.

NRG1-ErbB4 signaling in the medial amygdala controls mating motivation in adult male mice.

Autor: Huang J; Department of Anesthesiology, Shenzhen Hospital, Southern Medical University, Shenzhen, China., Zhang YY; Department of Neurology, Institute of Neuroscience, Key Laboratory of Neurogenetics and Channelopathies of Guangdong Province and the Ministry of Education of China, and Emergency Department of the Second Affiliated Hospital, School of Basic Medicine, Guangzhou Medical University, Guangzhou, China., Qiu YY; Department of Neurology, Institute of Neuroscience, Key Laboratory of Neurogenetics and Channelopathies of Guangdong Province and the Ministry of Education of China, and Emergency Department of the Second Affiliated Hospital, School of Basic Medicine, Guangzhou Medical University, Guangzhou, China., Yao S; Department of Neurology, Institute of Neuroscience, Key Laboratory of Neurogenetics and Channelopathies of Guangdong Province and the Ministry of Education of China, and Emergency Department of the Second Affiliated Hospital, School of Basic Medicine, Guangzhou Medical University, Guangzhou, China., Qiu WT; Department of Neurology, Institute of Neuroscience, Key Laboratory of Neurogenetics and Channelopathies of Guangdong Province and the Ministry of Education of China, and Emergency Department of the Second Affiliated Hospital, School of Basic Medicine, Guangzhou Medical University, Guangzhou, China., Peng JL; Guangzhou Medical University-Guangzhou Institute of Biomedicine and Health (GMU-GIBH) Joint School of Life Sciences, Guangzhou Medical University, Guangzhou, China., Li YQ; Department of Neurology, Affiliated Qingyuan Hospital, Guangzhou Medical University, Qingyuan People's Hospital, Qingyuan, China., You QL; Department of Neurology, Institute of Neuroscience, Key Laboratory of Neurogenetics and Channelopathies of Guangdong Province and the Ministry of Education of China, and Emergency Department of the Second Affiliated Hospital, School of Basic Medicine, Guangzhou Medical University, Guangzhou, China., Wu CH; Department of Neurology, Institute of Neuroscience, Key Laboratory of Neurogenetics and Channelopathies of Guangdong Province and the Ministry of Education of China, and Emergency Department of the Second Affiliated Hospital, School of Basic Medicine, Guangzhou Medical University, Guangzhou, China., Wu EJ; Department of Neurology, Institute of Neuroscience, Key Laboratory of Neurogenetics and Channelopathies of Guangdong Province and the Ministry of Education of China, and Emergency Department of the Second Affiliated Hospital, School of Basic Medicine, Guangzhou Medical University, Guangzhou, China., Wang J; Department of Physiology, Guangxi University of Science and Technology, Liuzhou, China., Zhou YL; Department of Psychiatry, Affiliated Brain Hospital of Guangzhou Medical University, Guangzhou, China., Ning YP; Department of Psychiatry, Affiliated Brain Hospital of Guangzhou Medical University, Guangzhou, China., Wang HS; Songjiang Research Institute, Shanghai Songjiang District Central Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China., Chen WB; Department of Neurology, Institute of Neuroscience, Key Laboratory of Neurogenetics and Channelopathies of Guangdong Province and the Ministry of Education of China, and Emergency Department of the Second Affiliated Hospital, School of Basic Medicine, Guangzhou Medical University, Guangzhou, China., Hu BJ; Department of Neurology, Institute of Neuroscience, Key Laboratory of Neurogenetics and Channelopathies of Guangdong Province and the Ministry of Education of China, and Emergency Department of the Second Affiliated Hospital, School of Basic Medicine, Guangzhou Medical University, Guangzhou, China. Electronic address: hubingjie@gzhmu.edu.cn., Liu Y; Department of Anesthesiology, Shenzhen Hospital, Southern Medical University, Shenzhen, China. Electronic address: youtanliuhao@163.com., Sun XD; Department of Anesthesiology, Shenzhen Hospital, Southern Medical University, Shenzhen, China; Key Laboratory of Mental Health of the Ministry of Education, Guangdong-Hong Kong-Macao Greater Bay Area Center for Brain Science and Brain-Inspired Intelligence, Guangdong-Hong Kong Joint Laboratory for Psychiatric Disorders, Guangdong Province Key Laboratory of Psychiatric Disorders, Guangdong Basic Research Center of Excellence for Integrated Traditional and Western Medicine for Qingzhi Diseases, Department of Neurobiology, School of Basic Medical Sciences, Southern Medical University, Guangzhou, China. Electronic address: xisun@smu.edu.cn.

Publikováno v: Cell reports [Cell Rep] 2024 Mar 26; Vol. 43 (3), pp. 113905. Date of Electronic Publication: 2024 Mar 05.

Supporting suture combined scleral fixation of toric IOL implantation in traumatic aniridia, aphakia and corneal astigmatic eye: a case report.

Autor: Shao Y; Tianjin Key Laboratory of Retinal Functions and Diseases, Tianjin Branch of National Clinical Research Center for Ocular Disease, Eye Institute and School of Optometry, Tianjin Medical University Eye Hospital, Tianjin 384300, China., Luan R; Tianjin Key Laboratory of Retinal Functions and Diseases, Tianjin Branch of National Clinical Research Center for Ocular Disease, Eye Institute and School of Optometry, Tianjin Medical University Eye Hospital, Tianjin 384300, China., Liu JP; Tianjin Key Laboratory of Retinal Functions and Diseases, Tianjin Branch of National Clinical Research Center for Ocular Disease, Eye Institute and School of Optometry, Tianjin Medical University Eye Hospital, Tianjin 384300, China., Hu BJ; Tianjin Key Laboratory of Retinal Functions and Diseases, Tianjin Branch of National Clinical Research Center for Ocular Disease, Eye Institute and School of Optometry, Tianjin Medical University Eye Hospital, Tianjin 384300, China., Li XR; Tianjin Key Laboratory of Retinal Functions and Diseases, Tianjin Branch of National Clinical Research Center for Ocular Disease, Eye Institute and School of Optometry, Tianjin Medical University Eye Hospital, Tianjin 384300, China.

Publikováno v: International journal of ophthalmology [Int J Ophthalmol] 2023 Sep 18; Vol. 16 (9), pp. 1559-1560. Date of Electronic Publication: 2023 Sep 18 (Print Publication: 2023).

Safety and immunogenicity of a modified COVID-19 mRNA vaccine, SW-BIC-213, as a heterologous booster in healthy adults: an open-labeled, two-centered and multi-arm randomised, phase 1 trial.

Autor: Gui YZ; Shanghai Xuhui Central Hospital/Xuhui Hospital, Fudan University, Shanghai, China; Shanghai Engineering Research Center of Phase I Clinical Research & Quality Consistency Evaluation for Drugs, Shanghai, China., Li XN; Zhongshan Hospital, Fudan University, Shanghai, China., Li JX; Jiangsu Provincial Center for Disease Control and Prevention, Nanjing, China., Shen MY; StemiRNA Therapeutics Co., Ltd., Shanghai, China., Zhang MW; Shanghai Xuhui Central Hospital/Xuhui Hospital, Fudan University, Shanghai, China; Shanghai Engineering Research Center of Phase I Clinical Research & Quality Consistency Evaluation for Drugs, Shanghai, China., Cao Y; Shanghai Xuhui Central Hospital/Xuhui Hospital, Fudan University, Shanghai, China; Shanghai Engineering Research Center of Phase I Clinical Research & Quality Consistency Evaluation for Drugs, Shanghai, China., Xu HR; Zhongshan Hospital, Fudan University, Shanghai, China., Li H; Zhongshan Hospital, Fudan University, Shanghai, China., Cheng J; Zhongshan Hospital, Fudan University, Shanghai, China., Pan L; Shanghai Xuhui Central Hospital/Xuhui Hospital, Fudan University, Shanghai, China; Shanghai Engineering Research Center of Phase I Clinical Research & Quality Consistency Evaluation for Drugs, Shanghai, China., Yi YL; StemiRNA Therapeutics Co., Ltd., Shanghai, China., Liang LY; Shanghai Xuhui Central Hospital/Xuhui Hospital, Fudan University, Shanghai, China; Shanghai Engineering Research Center of Phase I Clinical Research & Quality Consistency Evaluation for Drugs, Shanghai, China., Yu CY; Shanghai Xuhui Central Hospital/Xuhui Hospital, Fudan University, Shanghai, China; Shanghai Engineering Research Center of Phase I Clinical Research & Quality Consistency Evaluation for Drugs, Shanghai, China., Liu GY; Shanghai Xuhui Central Hospital/Xuhui Hospital, Fudan University, Shanghai, China; Shanghai Engineering Research Center of Phase I Clinical Research & Quality Consistency Evaluation for Drugs, Shanghai, China., Yu C; Shanghai Xuhui Central Hospital/Xuhui Hospital, Fudan University, Shanghai, China; Shanghai Engineering Research Center of Phase I Clinical Research & Quality Consistency Evaluation for Drugs, Shanghai, China., Hu BJ; Zhongshan Hospital, Fudan University, Shanghai, China., Zhu FC; Jiangsu Provincial Center for Disease Control and Prevention, Nanjing, China., Liang F; Zhongshan Hospital, Fudan University, Shanghai, China., Shen H; StemiRNA Therapeutics Co., Ltd., Shanghai, China., Jia JY; Shanghai Xuhui Central Hospital/Xuhui Hospital, Fudan University, Shanghai, China; Shanghai Engineering Research Center of Phase I Clinical Research & Quality Consistency Evaluation for Drugs, Shanghai, China., Li HW; StemiRNA Therapeutics Co., Ltd., Shanghai, China., Zhou J; Zhongshan Hospital, Fudan University, Shanghai, China., Fan J; Zhongshan Hospital, Fudan University, Shanghai, China. Electronic address: fan.jia@zs-hospital.sh.cn.

Publikováno v: EBioMedicine [EBioMedicine] 2023 May; Vol. 91, pp. 104586. Date of Electronic Publication: 2023 Apr 24.

Substrate Integrated Waveguide Multi-Channel Filtering Crossover with Extended Channel Number and Controllable Frequencies

Autor: Zhan, WL, Xu, JX, Zhao, XL, Hu, BJ, Zhang, XY

© 2004-2012 IEEE. In this brief, substrate integrated waveguide (SIW) multi-channel filtering crossovers are proposed for two sets of intersecting signals operating at the same or different frequencies. The number of filtering channels in two direct

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od_______363::87a0d8e458507e610cc60615267a54cc
https://hdl.handle.net/10453/146955